Skip to main content

Table 1 Patient characteristics

From: Tophi and frequent gout flares are associated with impairments to quality of life, productivity, and increased healthcare resource use: Results from a cross-sectional survey

  Total sample
(n = 620)
M SD
Age, mean years (SD) 60.9 11.6
Duration of gout, years 12.0 10.7
  n %
Male 504 81%
Employed 234 38%
sUA level
  Unknown 448 72%
  <6 mg/dL/360 μmol/L 62 10%
  6-8 mg/dL/360-480 μmol/L 75 12%
  >8 mg/dL/480 μmol/L 35 6%
Current medications
  Allopurinol 319 51%
  Febuxostat 29 5%
  Probenecid 18 3%
  Benzbromarone 4 1%
  Other 97 16%
  None 194 31%
Flares in last 12 months
  Don’t recall 8 1%
  0 143 23%
  1-2 235 38%
  3 91 15%
  4-5 86 14%
  6+ 57 9%
Tophi
  Don’t know 195 31%
  0 349 56%
  1 29 5%
  2+ 47 8%